In Re Suboxone Direct Purchaser Antitrust Litigation

Dr. Russell Lamb was retained on behalf of a proposed class of direct purchasers of branded and generic Suboxone tablets and film in a class action involving allegations of anticompetitive pay-for-delay and hard-switch conduct. The Court certified the proposed class, noting the following regarding Dr. Lamb’s damages analysis: “Dr. Lamb’s expert report satisfies this standard. His report measures overcharge damages based on the difference between the actual price class members paid for branded Suboxone tablets and film and the prices the class would have paid for branded and generic tablets absent the allegedly anticompetitive conduct.”